Prostate cancer (non-metastatic).
作者信息
Wilt Timothy
机构信息
VA Coordinating Center for the Cochrane Review Group in Prostate Diseases and Urologic Malignancies and the Center for Chronic Diseases Outcomes Research, Minneapolis VA Hospital, Minneapolis, MN, USA.
出版信息
Clin Evid. 2003 Jun(9):973-85.
PMID:12967402
Abstract
摘要
相似文献
1
Prostate cancer (non-metastatic).
Clin Evid. 2003 Jun(9):973-85.
2
Prostate cancer (non-metastatic).
Clin Evid. 2003 Dec(10):1023-38.
3
Prostate cancer: non-metastatic.前列腺癌：非转移性。
Clin Evid. 2002 Jun(7):812-23.
4
Does androgen deprivation improve treatment outcomes in patients with low-risk and intermediate-risk prostate cancer?雄激素剥夺疗法能否改善低风险和中风险前列腺癌患者的治疗效果？
Nat Clin Pract Oncol. 2005 May;2(5):236-7. doi: 10.1038/ncponc0168.
5
[Endocrine therapy for localized or locally advanced prostate cancer].[局限性或局部晚期前列腺癌的内分泌治疗]
Prog Urol. 2004 Jun;14(3):433-6.
6
Treatment of early stage prostate cancer: conservative management--delayed therapy.早期前列腺癌的治疗：保守管理——延迟治疗。
Important Adv Oncol. 1994:241-4.
7
Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option.放射治疗后前列腺癌复发的管理——近距离放射治疗作为挽救性选择
Cancer. 2007 Oct 1;110(7):1405-16. doi: 10.1002/cncr.22940.
8
[Cancer of the prostate. What treatment, for which patient, in 1986?].[前列腺癌。1986年，针对哪些患者采用何种治疗方法？]
Ann Urol (Paris). 1986;20(2):79-81.
9
Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer.局限性前列腺癌初次手术后、放疗后或雄激素剥夺治疗后的风险调整死亡率比较结果。
Cancer. 2011 Aug 1;117(15):3532; author reply 3532-3. doi: 10.1002/cncr.25949. Epub 2011 Feb 1.
10
A randomized trial comparing radical prostatectomy plus endocrine therapy versus external beam radiotherapy plus endocrine therapy for locally advanced prostate cancer: results at median follow-up of 102 months.一项比较根治性前列腺切除术加内分泌治疗与外照射放疗加内分泌治疗对局部晚期前列腺癌疗效的随机试验：中位随访102个月的结果
Jpn J Clin Oncol. 2006 Dec;36(12):789-93. doi: 10.1093/jjco/hyl115. Epub 2006 Nov 2.
Zotero 插件